Highlights Nuwellis, Inc.

Equities

NUWE

US67113Y4052

Real-time Estimate Cboe BZX Other stock markets 02:35:02 2024-05-17 pm EDT			5-day change	1st Jan Change
0.267 ^USD	-2.48%		+9.83%	-52.30%

May. 07	Top Midday Gainers	MT
May. 07	Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Midday Gainers	May. 07	MT
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Earnings Flash (NUWE) NUWELLIS Reports Q1 Revenue $1.9M, vs. Street Est of $2M	May. 07	MT
Nuwellis, Inc. Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology	May. 02	CI
Nuwellis, Inc. Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health	Apr. 09	CI
Nuwellis, Inc. Announces Results from Two New Clinical Data Analyses from the AVOID-HF Trial, Which Demonstrate the Benefits of its Aquadex System in Reducing Heart Failure Readmissions at 30 Days	Mar. 07	CI
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 06	CI
Earnings Flash (NUWE) NUWELLIS Reports Q4 Revenue $2.6M	Mar. 05	MT
Nuwellis, Inc. Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter	Jan. 04	CI
Nuwellis, Inc. Announces New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring Foriatric Patients	Nov. 28	CI
Nuwellis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Earnings Flash (NUWE) NUWELLIS Reports Q3 Revenue $2.4M	Nov. 07	MT
Nuwellis Provides Regulatory Update on Seastar Medical's Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under A Humanitarian Device Exemption	23-10-10	CI
Earnings Flash (NUWE) NUWELLIS Reports Q2 Revenue $2.1M, vs. Street Est of $2.19M	23-08-08	MT
Nuwellis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Nuwellis Signs Supply, Collaboration Agreement With DaVita for Aquadex Ultrafiltration Therapy Pilot Program	23-06-20	MT
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Earnings Flash (NUWE) NUWELLIS Reports Q1 Revenue $1.8M, vs. Street Est of $2.3M	23-05-09	MT
Nuwellis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01	CI
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Nuwellis, Inc.

Equities

NUWE

US67113Y4052

Highlights

Filters